Mach7 Technologies (M7T) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
29 May, 2026Executive summary
Achieved 16% year-over-year revenue growth to A$33.8M, in line with guidance, with recurring revenue rising 20% to A$25.3M, now 75% of total revenue and covering 80% of OPEX.
Operating cash flow turned positive, with A$23.1M cash and no debt at year-end.
Leadership renewal included new CEO and Chief Innovation Officer appointments, and transformation of customer-facing operations.
Implemented a new customer engagement model, receiving highly positive feedback and driving improved customer satisfaction.
Strategic focus on value-centric growth, customer-centricity, and leveraging global talent.
Financial highlights
Revenue increased by A$4.7M (+16%) year-over-year to A$33.8M; recurring revenue up A$4.3M (+20%) to A$25.3M.
Adjusted EBITDA improved to -A$0.3M from -A$2.0M; NPATA at A$0.4M, NPAT at -A$6.2M.
Operating expenses rose 9% to A$31.8M, below revenue growth; H2 OPEX up only 3%.
Cash receipts from customers up 2% to A$35.7M.
On-market share buy-back acquired 6.3M shares for A$2.2M in H2 FY25.
Outlook and guidance
Strategic review underway; new growth strategy and FY26 guidance to be released in Q2 FY26.
Focus for FY26 is on ideal customer targeting, sales effectiveness, and new logo acquisition.
Continued investment in subscription sales in North America to drive recurring revenue.
Share buy-back program paused pending completion of strategic review.
Latest events from Mach7 Technologies
- Record recurring revenue and sales orders drive positive cash flow and strong FY25 outlook.M7T
H2 202429 May 2026 - Revenue up 33%, recurring revenue covers 80% of OpEx, positive EBITDA, and share buy-back announced.M7T
H1 202529 May 2026 - Revenue fell 23% year-over-year, but recurring revenue and cost discipline support future growth.M7T
H1 202629 May 2026 - Q3 FY26 saw positive cash flow, ARR growth, and a strong cash position amid cost discipline.M7T
Q3 202624 Apr 2026 - Stable ARR, positive cash flow, and new product traction support a confident outlook.M7T
Q2 20263 Feb 2026 - Sales orders up 52%, recurring revenue and cash at record highs, subscription growth strong.M7T
Q4 2024 TU2 Feb 2026 - CARR and ARR rose in Q1 FY25, with strong cash reserves and reaffirmed growth guidance.M7T
Q1 2025 TU17 Jan 2026 - Record sales and recurring revenue growth support a scalable, innovation-driven outlook for FY25.M7T
AGM 202412 Jan 2026 - Recurring revenue up 15.6%, strong cash, and FY25 growth guidance reaffirmed.M7T
Q2 2025 TU9 Jan 2026